Results 251 to 260 of about 2,285,924 (374)

Myelodysplastic syndrome.

Nihon Naika Gakkai Zasshi, 1993
openaire   +3 more sources

Post‐Transplant Cyclophosphamide for Graft‐Versus‐Host Disease Prophylaxis in Pediatric Stem Cell Transplantation

Pediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
ABSTRACT Graft‐Versus‐Host disease (GVHD) is a leading contributor to morbidity and mortality following stem cell transplantation (SCT). Current GVHD prevention methods utilize a combination of immunosuppressive drugs to prevent injury to host tissues.
Aaron E. Fan, Wilson Andres Vasconez, Ramya Ramakrishnan, Priti Tewari, Amanda Olson, Elizabeth J. Shpall, Irtiza N. Sheikh   +6 more
wiley   +1 more source

Progress in the Genetics of Myelodysplastic Syndromes with a Latin American Perspective. [PDF]

Genes (Basel)
Basquiera AL, Andreoli V, Grille S, Belli CB.   +3 more
europepmc   +1 more source

Megakaryocytopoiesis in Chronic Myelogenous Leukemia, Myelodysplastic Syndrome and Idiopathic Thrombocytopenic Purpura

, 1993
Katsuyuki Kitoh, Hidetoshi Okabe, Yoshihide Fujiyama, Keiko Hodohara, Shiro Hosoda   +4 more
openalex   +2 more sources

Telomere length in myelodysplastic syndromes [PDF]

, 1997
Jacqueline Boultwood, Carrie Fidler, Rajko Kušec, Katrina Rack, P Elliott, Oluwole Atoyebi, Robert M. Chapman, David Oscier, J. S. Wainscoat   +8 more
openalex   +1 more source

Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation in Children: A Single Pediatric Center Experience

Pediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
ABSTRACT Background Hemorrhagic cystitis (HC) is a frequent and potentially severe complication following hematopoietic stem cell transplantation (HSCT) in children. It significantly affects the quality of life and prolongs hospitalization. Despite its frequency, no standardized management guidelines exist.
Pauline Mazilier, Laurence Dedeken, Eleonore Powis, Pierluigi Calò, Stéphane Luyckx, Laure Kornreich, Safiatou Diallo, Adriano Salaroli, Christine Devalck   +8 more
wiley   +1 more source

A case of familial colorectal adenoid tumor complicating myelodysplastic syndrome.

, 1994
但馬 史人, 遠藤 章, 川谷 俊夫, 梅木 健介, 吉村 禎二, 川崎 寛中, 古城 治彦, 乗本 道子   +7 more
openalex   +2 more sources

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2017
P. Greenberg, R. Stone, A. Al-Kali, S. Barta, R. Bejar, J. Bennett, H. Carraway, Carlos M. de Castro, H. Deeg, A. DeZern, A. Fathi, O. Frankfurt, K. Gaensler, G. Garcia-Manero, E. Griffiths, D. Head, R. Horsfall, Robert A. Johnson, M. Juckett, V. Klimek, R. Komrokji, Lisa A Kujawski, L. Maness, M. O'donnell, D. Pollyea, P. Shami, B. Stein, A. Walker, P. Westervelt, A. Zeidan, Dorothy Shead, Courtney Smith   +31 more
semanticscholar   +1 more source

Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience

American Journal of Hematology, Volume 100, Issue 11, Page 1963-1971, November 2025.
ABSTRACT Breakthrough hemolysis (BTH) is defined as a hemolytic exacerbation in a patient with paroxysmal nocturnal hemoglobinuria (PNH) treated with complement inhibitors (CIs). In the current era of several terminal and proximal inhibitors, there are no guidelines for defining BTH and its severity, and clinical management is not standardized.
Bruno Fattizzo, Giacinto Luca Pedone, Elisabetta Metafuni, Eloise Beggiato, Valentina Giai, Esther Natalie Oliva, Antony Ricchiuti, Marta Bortolotti, Simona Raso, Daniela Carlino, Mara Memoli, Sofia Vecchi, Jennifer Vidler, Sukanya Gogoi, Shreya Goel, Anna Corby, Roochi Trikha, Sneha Balakrishnan, Francesco Passamonti, Anna Paola Iori, Simona Sica, Shreyans Gandhi, Wilma Barcellini, Austin Kulasekararaj   +23 more
wiley   +1 more source

Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial. [PDF]

EClinicalMedicine
Pollyea DA, Stevens BM, Abbott D, Amaya M, Gutman JA, Kent A, McMahon C, Schwartz M, Smith C, Dell-Martin J, Sohalski C, Ellis A, Haag M, Schowinsky J, Pan Z, Patel SB, Ransom M, Gillen A, Jordan CT, Pietras EM.   +19 more
europepmc   +1 more source